CoChat

The Financial Impact of Inaccurate Blood Glucose Monitoring Systems

Open access
Fortwaengler, Kurt, Campos-Náñez, Enrique, Parkin, Christopher G., Breton, Marc D. · 2018 · Journal of Diabetes Science and Technology

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Objective: An in silico study of type 1 diabetes (T1DM) patients utilized the UVA-PADOVA Type 1 Diabetes Simulator to assess the effect of patient blood glucose monitoring (BGM) system accuracy on clinical outcomes. We applied these findings to assess the financial impact of BGM system inaccuracy. Methods: The study included 43 BGM systems previously assessed for accuracy according to ISO 15197:2003 and ISO 15197:2013 criteria. Glycemic responses for the 100 in silico adult T1DM subjects were generated, using each meter. Changes in estimated HbA1c, severe hypoglycemic events, and health care resource utilization were computed for each simulation. The HbA1c Translator modeling approach was used to calculate the financial impact of these changes. Results: The average cost of inaccuracy associated with the entire group of BGM systems was £155 per patient year (PPY). The average additional cost of BGM systems not meeting the ISO 15197:2003 standard was an estimated £178 PPY more than an average system that fulfills the standard and an estimated £235 PPY more than an average system that appears to meet the ISO 15197:2013 standard. Conclusion: There is a clear relationship between BGM system accuracy and cost, with the highest costs being associated with BGM systems not meeting the ISO 15197:2003 standard. Lower costs are associated with systems meeting the ISO 15197:2013 system accuracy criteria. Using BGM systems that meet the system accuracy criteria of the ISO 15197:2013 standard can help reduce the clinical and financial consequences associated with inaccuracy of BGM devices.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1932296817731423

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 2

  1. Bolli GB., 1997, Diabetes Metab, 23, 29
  2. Davidson JA, 2016, Am J Mang Care, 22, SP252

Cited by

See all 17

Metadata

Authors
Fortwaengler, K., Campos-Náñez, E., Parkin, C. G., & Breton, M. D.
Affiliations
  • Roche Diabetes Care GmbH (Germany) (DE)
  • University of Virginia (US)
  • CGParkin Communications, Inc, Boulder City, NV, USA
Corresponding author
Parkin, Christopher G.
Venue
Journal of Diabetes Science and Technology
Published
2017-09-26
Volume
12
Issue
2
Pages
318-324
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2758214362
Cited by
17
References
32
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 2
FWCI
1.08
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Roche Diabetes Care GmbH
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 1 diabetes, blood glucose meter accuracy, blood glucose monitoring systems, financial impact, HbA1c, hypoglycemia, healthcare resource utilization, ISO 15197, computer simulation
MeSH terms
Data Accuracy, Adolescent, Adult, Child, Computer Simulation, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemia, Male, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Financial Impact of Inaccurate Blood Glucose Monitoring Systems. https://app.cochat.ai/papers/10.1177/1932296817731423
The paper
Fortwaengler, K., Campos-Náñez, E., Parkin, C. G., & Breton, M. D. (2018). The Financial Impact of Inaccurate Blood Glucose Monitoring Systems. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296817731423

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.